Current Studies

On a website of the US National Institutes of Health many ongoing clinical studies are listed. Please note that this list is not complete.

Here are some of the many current clinical studies.

THC / Dronabinol / Marinol
Efficacy Trial of Oral Tetrahydrocannabinol in Patients With Fibromyalgia at Hadassah Medical Organization, Jerusalem, Israel.
For more studies please click here.

Nabilone / Cesamet
Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis at University of Manitoba, Winnipeg, Canada.
For more studies please click here.

Nabiximols / Sativex
A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer in the United States, the UK and Germany.
For more studies please click here.

Cannabidiol (CBD)
Cannabidiol for Inflammatory Bowel Disease at Meir Medical Center, Kefar Saba, Israel.
For more studies please click here.

Smoked / Inhaled Cannabis
Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS at New York State Psychiatric Institute, USA.
Effects of Vaporized Marijuana on Neuropathic Pain at CTSC Clinical Research Center, Sacramento, United States.
For more studies please click here.

Contact

You are here: Home > CANNABINOIDS > Treating depression with cannabinoids

Cannabinoids 2008;3(2):8-10 (22 June 2008)

Original article

Treating depression with cannabinoids

Kurt Blaas

Lindengasse 27/10, 1070 Vienna, Austria, drblaas@blowdoc.at

Although a variety of drugs are available for the treatment of depression, therapy is not effective in all cases and finding alternative options is desirable. Results from animal studies, anecdotal ex-perience reported by patients using cannabis and observations from clinical studies where can-nabinoids were used in serious diseases suggest an anti-depressive potential of cannabinoid recep-tor agonists. From 2003 to 2006, 75 patients suffering from depression, stress and burnout syn-drome were successfully treated in a practice for general medicine with the cannabis ingredient dronabinol, alone or in combination with other antidepressants. Two case studies will be pre-sented. The presented observations suggest that dronabinol has an antidepressive potential that can readily be used in medical practice.

Keywords
Depression, burnout, cannabinoid, cannabis, dronabinol

[ PDF of the full text ]

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.